Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation

Carcinogenesis

Volumn 28, Issue 3, 2007, Pages 639-647

  Puppala, D ^a   Gairola, C G ^b   Swanson, H I ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; APIGENIN; AROMATIC HYDROCARBON RECEPTOR; CHRYSIN; CIGARETTE SMOKE; CIGARETTE SMOKE CONDENSATE; CURCUMIN; CYTOCHROME P450 1A1; EMODIN; GALANGIN; HESPERETIN; HYPOXIA INDUCIBLE FACTOR 1BETA; KAEMPFEROL; LUTEOLIN; MORIN; NARINGENIN; PIPERINE; QUERCETIN; RESVERATROL;

AGAR MEDIUM; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENICITY; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; COMPLEX FORMATION; CONTROLLED STUDY; GENE CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; LUNG CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; REPORTER GENE; SIGNAL TRANSDUCTION; UPREGULATION;

ANTICARCINOGENIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DIMETHYL SULFOXIDE; FLAVANONES; FLAVONES; FLAVONOIDS; HUMANS; KAEMPFEROLS; LIVER TRANSPLANTATION; LUTEOLIN; RECEPTORS, ARYL HYDROCARBON; SMOKING; STILBENES;

EID: 34047191433     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl169     Document Type: Article

References (57)

1. Kewley,R.J., Whitelaw,M.L. and Chapman-Smith,A. (2004) The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol., 36, 189-204.
2. Denison,M.S. and Nagy,S.R. (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol., 43, 309-334.
3. Song,Z. and Pollenz,R.S. (2002) Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation, and gene regulation. Mol. Pharmacol., 62, 806-816.
4. Hecht,S.S. (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer, 3, 733-744.
5. Greenlee,R.T., Hill-Harmon,M.B., Murray,T. and Thun,M. (2001) Cancer statistics, 2001. CA Cancer J. Clin., 51, 15-36.
6. Peto,R., Lopez,A.D., Boreham,J., Thun,M., Heath,C.,Jr and Doll,R. (1996) Mortality from smoking worldwide. Br. Med. Bull., 52, 12-21.
7. Shimizu,Y., Nakatsuru,Y., Ichinose,M., Takahashi,Y., Kume,H., Mimura,J., Fujii-Kuriyama,Y. and Ishikawa,T. (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA, 97, 779-782.
8. Nakatsuru,Y., Wakabayashi,K., Fujii-Kuriyama,Y., Ishikawa,T., Kusama,K. and Ide,F. (2004) Dibenzo[A,L]pyrene-induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor-deficient mice. Int. J. Cancer, 112, 179-183.
9. Dertinger,S., Silverstone,A. and Gasiewicz,T. (1998) Influence of aromatic hydrocarbon receptor-mediated events on the genotoxicity of cigarette smoke condensate. Carcinogenesis, 19, 2037-2042.
10. Lu,Y.F., Santostefano,M., Cunningham,B.D., Threadgill,M.D. and Safe,S. (1995) Identification of 30-methoxy-40-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Arch. Biochem. Biophys., 316, 470-477.
11. Gasiewicz,T.A., Kende,A.S., Rucci,G., Whitney,B. and Willey,J.J. (1996) Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds. Biochem. Pharmacol., 52, 1787-1803.
12. Zhou,J. and Gasiewicz,T.A. (2003) 3′-methoxy-4′-nitroflavone, a reported aryl hydrocarbon receptor antagonist, enhances Cyp1a1 transcription by a dioxin responsive element-dependent mechanism. Arch. Biochem. Biophys., 416, 68-80.
13. Ciolino,H.P., Daschner,P.J., Wang,T.T. and Yeh,G.C. (1998) Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol., 56, 197-206.
14. Jeuken,A., Keser,B.J., Khan,E., Brouwer,A., Koeman,J. and Denison,M.S. (2003) Activation of the Ah receptor by extracts of dietary herbal supplements, vegetables, and fruits. J. Agric. Food Chem., 51, 5478-5487.
15. Ciolino,H.P., Daschner,P.J. and Yeh,G.C. (1999) Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J., 340, 715-722.
16. Ciolino,H.P. and Yeh,G.C. (1999) The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br. J. Cancer, 79, 1340-1346.
17. Ciolino,H.P. and Yeh,G.C. (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol., 56, 760-767.
18. Ashida,H. (2000) Suppressive effects of flavonoids on dioxin toxicity. Biofactors, 12, 201-206.
19. Amakura,Y., Tsutsumi,T., Sasaki,K., Yoshida,T. and Maitani,T. (2003) Screening of the inhibitory effect of vegetable constituents on the aryl hydrocarbon receptor-mediated activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biol. Pharm. Bull., 26, 1754-1760.
20. Reiners,J.J.Jr, Lee,J.Y., Clift,R.E., Dudley,D.T. and Myrand,S.P. (1998) PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol. Pharmacol., 53, 438-445.
21. Surh,Y.J. (2003) Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 3, 768-780.
22. Gescher,A.J., Sharma,R.A. and Steward,W.P. (2001) Cancer chemoprevention by dietary constituents: A tale of failure and promise. Lancet Oncol., 2, 371-379.
23. Santini,D.L., Rigas,B. and Shiff,S.J. (1999) Role of diet and NSAIDs in the chemoprevention of colorectal cancer. J. Assoc. Acad. Minor. Phys., 10, 68-76.
24. Vaisman,N. and Arber,N. (2002) The role of nutrition and chemoprevention in colorectal cancer: From observations to expectations. Best Pract. Res. Clin. Gastroenterol., 16, 201-217.
25. Kris-Etherton,P.M., Hecker,K.D., Bonanome,A., Coval,S.M., Binkoski,A.E., Hilpert,K.F., Griel,A.E. and Etherton,T.D. (2002) Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am. J. Med., 113(Suppl. 9B), 71S-88S.
26. Kris-Etherton,P.M. and Keen,C.L. (2002) Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol., 13, 41-49.
27. Schroeter,H., Boyd,C., Spencer,J.P., Williams,R.J., Cadenas,E. and Rice-Evans,C. (2002) MAPK signaling in neurodegeneration: Influences of flavonoids and of nitric oxide. Neurobiol. Aging, 23, 861-880.
28. Youdim,K.A., Spencer,J.P., Schroeter,H. and Rice-Evans,C. (2002) Dietary flavonoids as potential neuroprotectants. Biol. Chem., 383, 503-519.
29. Noda,Y., Anzai,K., Mori,A., Kohno,M., Shinmei,M. and Packer,L. (1997) Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem. Mol. Biol. Int., 42, 35-44.
30. Szewczuk,L.M., Forti,L., Stivala,L.A. and Penning,T.M. (2004) Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem., 279, 22727-22737.
31. Nakatsuka,T., Tomimori,Y., Fukuda,Y. and Nukaya,H. (2004) First total synthesis of structurally unique flavonoids and their strong anti-inflammatory effect. Bioorg. Med. Chem. Lett., 14, 3201-3203.
32. Agullo,G., Gamet-Payrastre,L., Manenti,S., Viala,C., Remesy,C., Chap,H. and Payrastre,B. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol., 53, 1649-1657.
33. Reiners,J.J.Jr, Clift,R. and Mathieu,P. (1999) Suppression of cell cycle progression by flavonoids: Dependence on the aryl hydrocarbon receptor. Carcinogenesis, 20, 1561-1566.
34. Plaumann,B., Fritsche,M., Rimpler,H., Brandner,G. and Hess,R.D. (1996) Flavonoids activate wild-type p53. Oncogene, 13, 1605-1614.
35. Narayan,S., Jaiswal,A.S., Kang,D., Srivastava,P., Das,G.M. and Gairola,C.G. (2004) Cigarette smoke condensate-induced transformation of normal human breast epithelial cells in vitro. Oncogene, 23, 5880-5889.
36. Heid,S.E., Walker,M.K. and Swanson,H.I. (2001) Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci., 61, 187-196.
37. Hoagland,M.S., Hoagland,E.M. and Swanson,H.I. (2005) The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor. J. Pharmacol. Exp. Ther., 314, 603-610.
38. Dolwick,K.M., Schmidt,J.V., Carver,L.A., Swanson,H.I. and Bradfield,C.A. (1993) Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol., 44, 911-917.
39. Denison,M.S., Vella,L.M. and Okey,A.B. (1986) Hepatic Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Partial stabilization by molybdate. J. Biol. Chem., 261, 10189-10195.
40. van Agen,B., Maas,L.M., Zwingmann,I.H., Van Schooten,F.J. and Kleinjans,J.C. (1997) B[a]P-DNA adduct formation and induction of human epithelial lung cell transformation. Environ. Mol. Mutagen., 30, 287-292.
41. Zhang,S., Qin,C. and Safe,S.H. (2003) Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context. Environ. Health Perspect., 111, 1877-1882.
42. Henry,E.C., Kende,A.S., Rucci,G., Totleben,M.J., Willey,J.J., Dertinger,S.D., Pollenz,R.S., Jones,J.P. and Gasiewicz,T.A. (1999) Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Mol. Pharmacol., 55, 716-725.
43. Holmes,J.L. and Pollenz,R.S. (1997) Determination of aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: Development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates. Mol. Pharmacol., 52, 202-211.
44. Ke,Y., Reddel,R.R., Gerwin,B.I., Miyashita,M., McMenamin,M., Lechner,J.F. and Harris,C.C. (1988) Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation, 38, 60-66.
45. Reddel,R.R., Ke,Y., Gerwin,B.I., McMenamin,M.G., Lechner,J.F., Su,R.T., Brash,D.E., Park,J.B., Rhim,J.S. and Harris,C.C. (1988) Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res., 48, 1904-1909.
46. Dertinger,S., Nazarenko,D., Silverstone,A. and Gasiewicz,T. (2001) Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis, 22, 171-177.
47. Revel,A., Raanani,H., Younglai,E., Xu,J., Rogers,I., Han,R., Savouret,J.F. and Casper,R.F. (2003) Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol., 23, 255-261.
48. Signorelli,P. and Ghidoni,R. (2005) Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises. J. Nutr. Biochem., 16, 449-466.
49. Jin,X., Nguyen,D., Zhang,W.W., Kyritsis,A.P. and Roth,J.A. (1995) Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res., 55, 3250-3253.
50. Braig,M., Lee,S., Loddenkemper,C., Rudolph,C., Peters,A.H., Schlegelberger,B., Stein,H., Dorken,B., Jenuwein,T. and Schmitt,C.A. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature, 436, 660-665.
51. Chen,C. and Kong,A.N. (2005) Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends. Pharmacol. Sci., 26, 318-326.
52. Niering,P., Michels,G., Watjen,W., Ohler,S., Steffan,B., Chovolou,Y., Kampkotter,A., Proksch,P. and Kahl,R. (2005) Protective and detrimental effects of kaempferol in rat H4IIE cells: Implication of oxidative stress and apoptosis. Toxicol. Appl. Pharmacol., 209, 114-122.
53. Harris,D.M., Besselink,E., Henning,S.M., Go,V.L. and Heber,D. (2005) Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp. Biol. Med. (Maywood), 230, 558-568.
54. Mollerup,S., Jorgensen,K., Berge,G. and Haugen,A. (2002) Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer, 37, 153-159.
55. Dasmahapatra,A.K., Wimpee,B.A., Trewin,A.L. and Hutz,R.J. (2001) 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases steady-state estrogen receptor-beta mRNA levels after CYP1A1 and CYP1B1 induction in rat granulosa cells in vitro. Mol. Cell Endocrinol., 182, 39-48.
56. Klinge,C.M., Kaur,K. and Swanson,H.I. (2000) The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1. Arch. Biochem. Biophys., 373, 163-174.
57. Matthews,J., Wihlen,B., Thomsen,J. and Gustafsson,J.A. (2005) Aryl hydrocarbon receptor-mediated transcription: Ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell Biol., 25, 5317-5328